Rituximab as first‐line adjuvant therapy for pemphigus: Retrospective analysis of long‐term outcomes at a single center
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American Academy of Dermatology"
DOI: 10.1016/j.jaad.2017.11.024
Abstract: Supported through the Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), and the NIH Medical Research Scholars Program, a publicprivate partnership supported jointly by… read more here.
Keywords: rituximab first; therapy pemphigus; research; first line ... See more keywords
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study
Sign Up to like & getrecommendations! Published in 2018 at "Haematologica"
DOI: 10.3324/haematol.2018.189837
Abstract: We performed an observational study on the efficacy of ben-damustine and rituximab (BR) as first salvage regimen in chronic lymphocytic leukemia (CLL). In an intention-to-treat analysis including 237 patients, the median progression-free survival (PFS) was… read more here.
Keywords: rituximab first; lymphocytic leukemia; treatment; first salvage ... See more keywords